Filing Details
- Accession Number:
- 0001493152-19-015454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-15 06:56:18
- Reporting Period:
- 2019-08-02
- Accepted Time:
- 2019-10-15 06:56:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260641 | C James Czirr | 545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324 | No | No | No | Yes | |
| 1453356 | 10X Fund, L.p. | 545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324 | No | No | Yes | No | |
| 1457247 | 10X Capital Management, Llc | 545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-02 | 38,690 | $0.00 | 6,402,790 | No | 4 | J | Direct | |
| Common Stock | Disposition | 2019-10-10 | 17,000 | $3.73 | 6,385,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | S | Direct |
Footnotes
- 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- Shares sold pursuant to 10X Fund, LP's Quarterly Liquidity Program.
- Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law.
Billionaire Hedge Funds
